全球組織診斷市場

預計到 2030 年全球組織診斷市場規模將達 95 億美元

全球組織診斷市場規模預計在2024年為65億美元，預計到2030年將達到95億美元，2024年至2030年的複合年成長率為6.6%。報告分析的細分市場之一——耗材——預計複合年成長率為6.8%，到分析期結束時規模將達到84億美元。設備細分市場在分析期間內的複合年成長率預計為5.2%。

美國市場規模估計為 22 億美元，中國市場預期複合年成長率為 9.2%

美國診斷市場規模預計2024年達到22億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到10億美元，在2024-2030年的分析期間內，複合年成長率為9.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.9%和6.2%。在歐洲，預計德國市場的複合年成長率為5.6%。

全球組織診斷市場—主要趨勢與促進因素摘要

什麼是組織診斷？為什麼它很重要？

組織病理學涉及透過分析組織樣本來診斷疾病，尤其是癌症。此領域涵蓋組織病理學、免疫組織化學、原位雜合反應和數位病理學等技術。組織病理學對於準確的疾病診斷、預後和治療計劃至關重要。它可以檢查細胞結構、識別異常細胞，並檢測與各種疾病相關的特定生物標記。組織病理學的準確性和可靠性對於指南臨床決策和改善患者預後至關重要。

科技進步如何影響這個市場？

技術進步正在顯著塑造組織診斷市場。數位病理學的發展，將組織樣本數位化以供分析和存儲，正在徹底改變這一領域。數位病理學實現了遠距會診，提高了診斷準確性，並促進了研究和教育的數據共用。高解析度掃描器和人工智慧驅動的影像分析等成像技術的進步，正在改善組織異常的檢測和表徵。此外，分子診斷與組織分析的結合，為深入了解疾病的遺傳和分子基礎提供了更深入的視角，從而帶來更個人化和標靶治療。

市場需求在這個產業扮演什麼角色？

市場需求正在推動組織診斷市場發生重大變化。癌症和其他慢性疾病的發生率不斷上升，推動了對準確及時診斷的需求，從而增加了對先進組織診斷工具的需求。個人化醫療的轉變需要詳細的分子和基因分析，這正在影響創新組織診斷技術的開發和應用。老年人口的成長，導致各種疾病的發生率更高，進一步增加了對先進診斷設備的需求。此外，對疾病早期發現和預防性醫療保健的日益重視，也促使實驗室和醫療機構投資於尖端組織診斷解決方案。

推動市場成長的因素有哪些？

組織診斷市場的成長受到多種因素的推動，例如癌症和其他慢性病盛行率的上升、診斷技術的進步以及醫療支出的增加。由於早期發現可顯著改善治療效果，對精準早期診斷工具的需求正在推動市場成長。數位病理學和人工智慧主導的診斷工具等技術創新正在提高疾病診斷的效率和準確性。此外，個人化醫療的日益成長趨勢推動了對能夠提供詳細分子和遺傳學見解的先進組織診斷技術的需求。新興市場醫療基礎設施的擴大以及政府為提高診斷能力所採取的措施也促進了市場的成長。這些因素共同導致了對組織診斷的強勁需求，從而推動了市場的發展。

部分

產品（耗材、儀器）、技術（免疫組織化學、原位雜合反應、特殊染色、數位病理學和工作流程）、最終用戶（醫院、製藥公司、研究實驗室、其他最終用戶）

受訪公司範例（總合61家）

• Abbott Laboratories
• Abcam plc
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio SB Inc.
• Bio-Genex Laboratories
• Cell Signaling Technology, Inc.
• F. Hoffmann-La Roche Ltd
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• QIAGEN NV
• Sakura Finetek Japan Co., Ltd.
• Thermo Fisher Scientific Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Tissue Diagnostics Market to Reach US$9.5 Billion by 2030

The global market for Tissue Diagnostics estimated at US$6.5 Billion in the year 2024, is expected to reach US$9.5 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 9.2% CAGR

The Tissue Diagnostics market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Tissue Diagnostics Market - Key Trends & Drivers Summarized

What Are Tissue Diagnostics and Their Importance?

Tissue diagnostics involves the analysis of tissue samples to diagnose diseases, particularly cancer. This field includes techniques such as histopathology, immunohistochemistry, in situ hybridization, and digital pathology. Tissue diagnostics is crucial for accurate disease diagnosis, prognosis, and treatment planning. It allows for the examination of cellular structures, the identification of abnormal cells, and the detection of specific biomarkers associated with various diseases. The precision and reliability of tissue diagnostics are vital for guiding clinical decisions and improving patient outcomes.

How Are Technological Advancements Shaping This Market?

Technological advancements are significantly shaping the tissue diagnostics market. The development of digital pathology, which involves the digitization of tissue samples for analysis and storage, is revolutionizing the field. Digital pathology enables remote consultations, enhances diagnostic accuracy, and facilitates the sharing of data for research and education. Advances in imaging technologies, such as high-resolution scanners and AI-powered image analysis, are improving the detection and characterization of tissue abnormalities. Additionally, the integration of molecular diagnostics with tissue analysis is providing deeper insights into the genetic and molecular underpinnings of diseases, leading to more personalized and targeted therapies.

What Role Do Market Demands Play in This Industry?

Market demands are driving significant changes in the tissue diagnostics market. The rising prevalence of cancer and other chronic diseases is increasing the need for accurate and timely diagnostics, boosting demand for advanced tissue diagnostic tools. The shift towards personalized medicine, which requires detailed molecular and genetic analysis, is influencing the development and adoption of innovative tissue diagnostics technologies. The expanding geriatric population, with its higher incidence of various diseases, further fuels the need for sophisticated diagnostic instruments. Moreover, the increasing focus on early disease detection and preventive healthcare is prompting laboratories and healthcare facilities to invest in cutting-edge tissue diagnostics solutions.

What Factors Are Driving Market Growth?

The growth in the tissue diagnostics market is driven by several factors, including the rising incidence of cancer and other chronic diseases, advancements in diagnostic technologies, and increasing healthcare expenditure. The demand for precise and early diagnostic tools is propelling market growth, as early detection can significantly improve treatment outcomes. Technological innovations, such as digital pathology and AI-driven diagnostic tools, are enhancing the efficiency and accuracy of disease diagnosis. Additionally, the growing trend towards personalized medicine is driving the need for advanced tissue diagnostics that can provide detailed molecular and genetic insights. The expansion of healthcare infrastructure in emerging markets, along with government initiatives to improve diagnostic capabilities, is also contributing to the market's growth. These factors collectively ensure a robust demand for tissue diagnostics, driving the market forward.

SCOPE OF STUDY:

The report analyzes the Tissue Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instruments); Technology (Immunohistochemistry, In Situ Hybridization, Special Staining, Digital Pathology & Workflow); End-Use (Hospitals, Pharma Companies, Research Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 61 Featured) -

• Abbott Laboratories
• Abcam plc
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio SB Inc.
• Bio-Genex Laboratories
• Cell Signaling Technology, Inc.
• F. Hoffmann-La Roche Ltd
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• QIAGEN N.V.
• Sakura Finetek Japan Co., Ltd.
• Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Tariff Impact on Global Supply Chain Patterns
  • Tissue Diagnostics: A Prelude
  • Global Economic Update
  • Global Market Outlook
  • Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
  • Breast Cancer Leads the Application Market for Tissue Diagnostics
  • Hospitals Represent the Leading End-Use Segment
  • Developed Regions Lead, Developing Economies to Spearhead Growth
  • Competition
  • Tissue Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Cancer Incidence Worldwide Spurs Demand for Tissue Diagnostics
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Expanding Role of Tissue Diagnostics in Oncology
  • Aging Population and Changing Lifestyles Drive Cancer Incidence, Fueling Prospects for Tissue Diagnostics Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Increasing Healthcare Spending Augurs Well for the Market
  • Growing Significance of Personalized Medicine: An Opportunity for Tissue Diagnostics Market
  • Global Personalized Medicines Market in US$ Billion for the Years 2022, 2024, 2026 and 2028
  • Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting Therapy Decisions in NSCLCs
  • Sustained Advancements in Tissue Diagnostics Space Fuel Market Prospects
  • Market to Benefit from Digitalization of Tissue Diagnostic Techniques & Automated Tissue Diagnostic Systems
  • Increase in Companion Diagnostics for Targeted Therapies
  • Companion Diagnostics Accelerate Role of Personalized Medicine in Cancer Care
  • Demand Continues to Surge for Digital Pathology
  • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
  • Future Developments in Digital Pathology to Influence Market Growth
  • AI Steps in to Widen the Scope & Span of Digital Pathology
  • Growing Importance of AI in Digital Pathology
  • CROs and Biopharma Companies Leverage Digital Pathology for Drug Discovery
  • Anatomic Pathology: Poised for Growth
  • Computational Pathology Holds the Potential to Transform Cancer Diagnostics
  • Constantly Increasing Number of Patients Suffering from Chronic Ailments Fuel Demand for Immunohistochemistry
  • Automated Tissue Dissection: Potential to Improve Precision of Molecular Tests
  • Tissue Diagnostics Market in India: An Overview
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Tissue Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Tissue Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Special Staining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Special Staining by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Digital Pathology & Workflow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Digital Pathology & Workflow by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pharma Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Research Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Tissue Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Tissue Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Tissue Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Tissue Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Tissue Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Tissue Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Product - Consumables and Instruments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Tissue Diagnostics by Product - Consumables and Instruments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Tissue Diagnostics by Product - Percentage Breakdown of Value Revenues for Consumables and Instruments for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Tissue Diagnostics by Technology - Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Tissue Diagnostics by Technology - Percentage Breakdown of Value Revenues for Immunohistochemistry, in Situ Hybridization, Special Staining and Digital Pathology & Workflow for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Tissue Diagnostics by End-Use - Hospitals, Pharma Companies, Research Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Tissue Diagnostics by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Pharma Companies, Research Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION